Prevalence and Predictors of Silent Gastroesophageal Reflux Disease in Patients with Hypertension
Table 3
Antihypertensive agents and other common comedication prescriptions of the two groups.
Drugs
Silent GERD ()
Non-GERD controls ()
/ value
value
Antihypertensive agents
Calcium channel blockers
44 (66.7)
156 (52.3)
0.474
0.034
ARBs
20 (30.3)
95 (31.9)
0.062
0.803
ACEIs
13 (19.7)
62 (20.8)
0.041
0.840
β-blockers
15 (22.7)
70 (23.5)
0.018
0.895
Diuretics
6 (9.1)
28 (9.4)
0.004
0.949
ARB/ACEI and diuretic compounds
3 (4.5)
10 (3.4)
0.011
0.917
Other antihypertensive agents
2 (3.0)
11 (3.7)
0.000
1.000
No antihypertensive agents
6 (9.1)
8 (2.7)
5.996
0.014
Comedication
Lipid-lowering agents
22 (33.3)
108 (36.2)
0.199
0.655
Antiplatelet agents
14 (21.2)
78 (26.1)
0.705
0.401
Antidiabetic medications
11 (61.1)
32 (56.1)
0.138
0.710
All results expressed as “ (%).” ARB: angiotensin receptor blockers; ACEI: angiotensin-converting enzyme inhibitors. compared with the control group. Based on 75 patients with diabetes mellitus.
